Search

Search Constraints

You searched for: Author/Creator Marhenke, Silke

Search Results

1. Absence of Atg7 in the liver disturbed hepatic regeneration after liver injury. (20th March 2020)

2. Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3‐kinase inhibitor BEZ235 and the PI3‐kinase inhibitor BKM120 in hepatocellular carcinoma. (15th March 2013)

3. Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9. Issue 10 (13th November 2014)

4. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. (October 2018)

5. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol‐related cirrhosis. (October 2018)

6. Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study. Issue 2 (4th July 2022)

7. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Issue 6 (1st August 2018)

8. Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer InVivo and In Vitro. Issue 3 (5th February 2019)

9. P21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury. Issue 9 (3rd October 2013)

10. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation‐associated liver carcinogenesis in mice12. Issue 1 (24th June 2013)